BioDelivery Sciences (BDSI) Acquires U.S. Commercial Rights to Symproic
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall Street ends sharply higher as Waller remarks ease rate hike fears
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
BioDelivery Sciences (BDSI) Commences Underwritten Public Offering of Common Stock
April 10, 2019 4:08 PM EDTBioDelivery Sciences International, Inc. (Nasdaq: BDSI) today announced that it is commencing an underwritten public offering of shares of common stock. In addition, the underwriters will have a 30-day option to purchase from a selling stockholder up to an additional 15% of the shares of common stock offered in the public offering at the public offering price less the underwriting... More
